Search results for: Vaccines
Filter search results
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
…regulatory support for pre-competitive consortia Hybrid Orphan drug legislation Vaccines and drugs to counter chemical, biological, radiological and nuclear (CBRN) threats, including Project BioShield The authors argue that push incentives…
Presentations from ISPOR and HTAi 2018
12 July 2018
…HTA in Incentivising New Drugs and Vaccines to Tackle AMR from Office of Health Economics Optimizing the Use of RWE in HTA: the ICER Membership Summit 2017 from Office…
Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA
31 January 2019
…S. and Devlin, N., 2016. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review. Value in Health, 19, pp.255-266. DOI. Kreimeier, S., Oppe, M.,…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast…
28 March 2019
…arrangements such as PAHOs revolving fund for vaccines which also carries a single and “favoured nation” type clause. If buyers A (wealthy large market) and B (poorer and smaller market)…
Adult Versus Adolescent Preferences for EQ-5D-Y Health States
15 April 2019
…for Economic Evaluation of Pediatric Vaccines: A Systematic Review. Value in Health, 19, pp.255-266. DOI. Kreimeier, S., Oppe, M., Ramos-Goñi, J.M., Cole, A., Devlin, N.J., Herdman, M., Mulhern, B., Shah,…
OHE Presents at Global AMR R&D Hub Board of Members Meeting in Paris
18 December 2019
…The advanced modelling approaches that are used for vaccines could be transferred to antibiotics to model the patterns of transmission and herd immunity. Contracting for new antibiotics needs to move…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…a wide range of child health care, including prevention (e.g. vaccines) and new treatments for childhood illness. An inability to capture QALYs for children in a way that makes them…
A Final MVAC Blueprint—and the Start of an R&D Revolution?
6 February 2020
…MVAC builds on the Advance Market Commitment (AMC) mechanism previously used in global health for pneumococcal vaccines. The MVAC has several important innovations and improvements. Most crucially, the MVAC is…
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
26 March 2020
…was given in Nov 2019; draft documents are expected in March /April 2020. Like the UK, Australia has high quality HTA valuation expertise for new vaccines and for new drugs….